Sickle cell disease complicated by post-streptococcal glomerulonephritis, cerebral hemorrhage and reversible posterior leucoencephalopathy syndrome

Pediatric Blood and Cancer

Volumn 50, Issue 4, 2008, Pages 864-866

  Pashankar, Farzana D ^a   Ment, Laura R ^a   Pearson, Howard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute post streptococcal glomerulonephritis (APSGN); Reversible posterior leucoencephalopathy syndrome (RPLS); Sickle cell disease

Indexed keywords

ALLERGIC GLOMERULONEPHRITIS; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HOMOZYGOTE; HUMAN; HYPERTENSION; LEUKOENCEPHALOPATHY; MALE; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; CEREBRAL HEMORRHAGE; CHILD; GLOMERULONEPHRITIS; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; STREPTOCOCCAL INFECTIONS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 40449113760     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21321     Document Type: Article

References (16)

1. DeBaun M, Kirkham FJ. Stroke in children with sickle cell disease. Curr Treatment Options Neurol 2004;6:357-375.
2. Hoppe C. Defining stroke risk in children with sickle cell anemia. Br J Haematol 2005;128:751-766.
3. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leucoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
4. Primavera A, Audenino D, Mavilio N, et al. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rhem Dis 2001;60:534-537.
5. Poon WL, Mok CC. Reversible posterior leucoencephalopathy in scleroderma. Ann Rheum Dis 2005;64:1803-1804.
6. Ozcakar ZB, Ekim M, Fitoz S, et al. Hypertension induced reversible posterior leucoencephalopathy syndrome: A report of two cases. Eur J Pediatr 2004;163:728-730.
7. Morris EB, Laningham FH, Sandlund JT, et al. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 2007;48:152-159.
8. Renard D, Westhovens R, Vandenbussche E, et al. Reversible posterior leucoencephalopathy during oral treatment with methotrexate. J Neurol 2004;251:226-228.
9. Mavragani CP, Vlachoyiannopoulos PG, Kosmas N, et al. A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology 2004;43:1450-1451.
10. Henderson JN, Noetzel MJ, McKinstry RC, et al. Reversible posterior leucoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood 2003;101:4-15-419.
11. Balal M, Paydas S, Seyrek N, et al. Different glomerular pathologies in sickle cell anemia. Clin Nephrol 2004;62:400-401.
12. Scheinman JI. Sickle cell disease and the kidney. Semin Nephrol 2003;23:66-76.
13. Wesson DE. The initiation and progression of sickle cell nephropathy. Kidney Int 2002;61:2277-2286.
14. Assar R, Pitel PA, Lammert NL, et al. Acute poststreptococcal glomerulonephritis and sickle cell disease. Clin Nephrol Urol 1988-1989;9:176-179.
15. Roy S, Murphy WM, Pitcock JA, et al. Sickle cell disease and poststreptococcal acute glomerulonephritis. Am J Clin Pathol 1976;66:986-990.
16. Susmano S, Lewy JE. Sickle cell disease and acute glomerulonephritis. Am J Dis Child 1969;118:615-618.